Brainstorm Cell Therapeutics reported $58K in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Adamis Pharmaceuticals ADMP:US USD 1.55M 597.95K
Biogen BIIB:US USD 1.98B 19.3M
Brainstorm Cell Therapeutics BCLI:US USD 58K 59K
Cytokinetics CYTK:US USD 2.29M 321K
Gilead Sciences GILD:US USD 4.35B 236M
Halozyme Therapeutics HALO:US USD 233.3M 43.93M